Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab

Technology appraisal guidance
Reference number: TA357
Published: 07 October 2015
Last updated: 12 September 2017

History

Documents created during the development process.

Invitation to participate

Equality Impact Assessment (Guidance development) (PDF 155 KB)

Published:

02 November 2015

Final appraisal determination

Final appraisal determination information
Final appraisal determination document
Final appraisal determination document (PDF 322 KB)

Published:

08 September 2015
Committee papers information
Committee papers (PDF 7.98 MB)

Published:

07 September 2015

Scope consultation comments table

Scope consultation comments table
Scope consultation comments table (PDF 208 KB)

Published:

26 February 2015

Final scope

Final scope
Final scope (PDF 101 KB)

Published:

26 February 2015

Equality impact assessment

Equality impact assessment
Equality impact assessment (PDF 121 KB)

Published:

26 February 2015

Final matrix

Final matrix
Final matrix (PDF 101 KB)

Published:

26 February 2015